Claims for refugee status related to situations of armed conflict and violence under Article 1A(2) of the 1951 Convention and/or 1967 Protocol relating to the Status of Refugees and the regional refugee definitions
UNHCR issues these Guidelines on International Protection pursuant to its mandate,... as contained in, inter alia, the Statute of the Office of the United Nations High Commissioner for Refugees, namely paragraph 8(a), in conjunction with Article 35 of the 1951 Convention relating to the Status of Refugees, Article II of its 1967 Protocol, Article VIII(1) of the 1969 OAU Convention Governing the Specific Aspects of Refugee Problems in Africa, and Commitment II(e) of the 1984 Cartagena Declaration on Refugees.
These Guidelines clarify paragraph 164 of the UNHCR Handbook on Procedures and Criteria for Determining Refugee Status under the 1951 Convention and otherwise complement the Handbook. They are to be read in conjunction with UNHCR’s other Guidelines on International Protection.
more
Accessed 15th of October 2015
This handbook provides an overview of the law applicable to asylum, border management and immigration in relation to European Union (EU) law and the European Convention on Human Rights (ECHR). It looks at the situation of those foreigners whom the EU usually refers to as third-country nationals. Thi...s handbook is designed to assist legal practitioners as well as non-governmental organisations (NGOs) and other bodies that are not specialised in the field of asylum, borders and immigration law and that may be confronted with legal qüstions relating to these subjects.
For versions in other European languages check also http://fra.europa.eu/de/publication/2013/handbuch-zu-den-europarechtlichen-grundlagen-im-bereich-asyl-grenzen-und-migration
more
Once identified as vulnerable, applicants enjoy specific rights and safeguards in the asylum process under EU law. Vulnerability should therefore trigger additional or tailored support to ensure that people have the necessary conditions to bring forward a claim for protection.
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
La Politique de protection de l’enfance de CBM s’appuie sur la Convention des Nations unies relatives aux droits de l’enfant de 1989 (et sur ses protocoles facultatifs), sur la législation allemande en matière de protection de l’enfance, sur les législations nationales des pays dans lesqu...els CBM mène ses actions ainsi que sur les normes proposées par la coalition Keeping Children Safe. Nous avons développé cette politique parce que garantir le respect de la dignité de tous les enfants et assurer leur sécurité comptent parmi les principes fondamentaux du travail de CBM. Dans le cadre de cette politique, est considérée comme enfant toute personne âgée de moins de 18 ans. CBM s’engage à créer un environnement garantissant la sécurité des enfants. Pour ce faire, nous investissons dans les ressources nécessaires à l’application des procédures détaillées dans ce texte.
more
A la suite de cette analyse de situation, le Ministère de la Santé à travers la Direction des Laboratoires a entrepris des actions correctives parmi lesquelles, l’élaboration d’une politique nationale en matière d’analyses de biologie médicale dont l’un des objectifs spécifiques est ...d’assurer la qualité des prestations. Nonobstant cet acquis, il reste que le Burkina Faso n’est pas doté d’un plan national qualité pour accompagner les laboratoires dans la mise en œuvre de la démarche qualité.
Le présent plan qualité vise la promotion et la mise en œuvre de la démarche qualité dans les laboratoires d’analyses de biologie médicale.
more
Rapporto ISS COVID-19, n. 3/2020
Gruppo di Lavoro ISS Ambiente e Gestione dei Rifiuti
aggiornato al 14 marzo 2020
Zarazne bolesti kao što je virus COVID-19 mogu poremetiti okruženje u kojem djeca rastu i razvijaju se. Remećenje u odnosu sa porodicom, prijateljima, svakodnevnim aktivnostima i široj zajednici može imati negativne posljedice na dobrobit, razvoj i zaštitu djece. Pored toga, mjere koje se pri...mjenjuju kako bi se spriječilo i suzbilo širenje virusa COVID-19 mogu djecu izložiti rizicima u pogledu njihove zaštite. Karantin i mjere izolacije u kućama, objektima i određenim zonama mogu imati negativan utjecaj na djecu i njihove porodice.
Cilj ovog dokumenta je da pruži podršku stručnjacima koji rade na polju zaštite djece kako bi na bolji način odgovorili na rizike za zaštitu djece za vrijeme pandemije virusa COVID-19. U prvom dijelu govori se o tome kakav rizik virus COVID-19 može predstavljati za djecu u smislu njihove zaštite. U drugom dijelu izložene su programske opcije u skladu s Minimalnim standardima za zaštitu djece u humanitarnim akcijama iz 2019. godine (CPMS) i Smjernicama: Zaštita djece za vrijeme epidemija zaraznih bolesti.
more
Un guide pour prévenir et combattre la stigmatisation sociale
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mit...igate the potential risk to the safety and sufficiency of the blood supplies during the pandemic.
It should be read in conjunction with WHO Guidance for National Blood Services on Protecting the Blood Supply During Infectious Disease Outbreaks, which provides general guidance on the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply.
more
orientations provisoires, 14 juin 2021
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.